<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00470000_3</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P62158</UniProt_ID>
  <Seq_Length>149</Seq_Length>
  <Molecule_Weight>16838</Molecule_Weight>
  <KEGG_ID>hsa:801</KEGG_ID>
  <Orthology_ID>K02183</Orthology_ID>
  <EBI_ID>EBI-397435</EBI_ID>
  <Function_Summary>Calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins by Ca(2+). Among the enzymes to be stimulated by the calmodulin-Ca(2+) complex are a number of protein kinases and phosphatases. Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis.</Function_Summary>
  <Pfam_ID>PF13499:EF-hand_7</Pfam_ID>
  <Allosteric_Activator_Count>7</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>CaM</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with calcium ions (Ca2+).</Detail>
      <Keyword>Calcium ion binding</Keyword>
      <Ontology_ID>GO:0005509</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Increases the activity of a protein phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a protein substrate molecule.</Detail>
      <Keyword>Protein phosphatase activator activity</Keyword>
      <Ontology_ID>GO:0072542</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient.</Detail>
      <Keyword>Ion channel binding</Keyword>
      <Ontology_ID>GO:0044325</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any phospholipase, enzymes that catalyze of the hydrolysis of a glycerophospholipid.</Detail>
      <Keyword>Phospholipase binding</Keyword>
      <Ontology_ID>GO:0043274</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Modulates the activity of nitric oxide synthase.</Detail>
      <Keyword>Nitric-oxide synthase regulator activity</Keyword>
      <Ontology_ID>GO:0030235</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a specific domain of a protein.</Detail>
      <Keyword>Protein domain specific binding</Keyword>
      <Ontology_ID>GO:0019904</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with titin, any of a family of giant proteins found in striated and smooth muscle. In striated muscle, single titin molecules span half the sarcomere, with their N- and C-termini in the Z-disc and M-line, respectively.</Detail>
      <Keyword>Titin binding</Keyword>
      <Ontology_ID>GO:0031432</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.</Detail>
      <Keyword>Protein kinase binding</Keyword>
      <Ontology_ID>GO:0019901</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the N-terminus of a protein that has the potential to be, or has been, modified by N-terminal myristoylation. Binding affinity is typically altered by myristoylation; for example, N-terminal myristoylation of HIV Nef increases its affinity for calmodulin.</Detail>
      <Keyword>N-terminal myristoylation domain binding</Keyword>
      <Ontology_ID>GO:0031997</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any thioesterase enzyme.</Detail>
      <Keyword>Thioesterase binding</Keyword>
      <Ontology_ID>GO:0031996</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Increases the activity of a protein serine/threonine kinase.</Detail>
      <Keyword>Protein serine/threonine kinase activator activity</Keyword>
      <Ontology_ID>GO:0043539</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the activity of a phosphoprotein phosphatase.</Detail>
      <Keyword>Positive regulation of phosphoprotein phosphatase activity</Keyword>
      <Ontology_ID>GO:0032516</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the nerve growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Nerve growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048011</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events in which a calcium ion stimulus is received by a cell and converted into a molecular signal.</Detail>
      <Keyword>Detection of calcium ion</Keyword>
      <Ontology_ID>GO:0005513</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the activity of a ryanodine-sensitive calcium-release channel. The ryanodine-sensitive calcium-release channel catalyzes the transmembrane transfer of a calcium ion by a channel that opens when a ryanodine class ligand has been bound by the channel complex or one of its constituent parts.</Detail>
      <Keyword>Negative regulation of ryanodine-sensitive calcium-release channel activity</Keyword>
      <Ontology_ID>GO:0060315</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the rate, frequency or extent of release of sequestered calcium ion into cytosol by the sarcoplasmic reticulum, the process in which the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol occurs via calcium release channels.</Detail>
      <Keyword>Regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum</Keyword>
      <Ontology_ID>GO:0010880</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the activity of the enzyme nitric-oxide synthase.</Detail>
      <Keyword>Regulation of nitric-oxide synthase activity</Keyword>
      <Ontology_ID>GO:0050999</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.</Detail>
      <Keyword>Positive regulation of protein autophosphorylation</Keyword>
      <Ontology_ID>GO:0031954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.</Detail>
      <Keyword>Positive regulation of peptidyl-threonine phosphorylation</Keyword>
      <Ontology_ID>GO:0010800</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.</Detail>
      <Keyword>Glucose metabolic process</Keyword>
      <Ontology_ID>GO:0006006</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.</Detail>
      <Keyword>Glycogen catabolic process</Keyword>
      <Ontology_ID>GO:0005980</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine.</Detail>
      <Keyword>Response to amphetamine</Keyword>
      <Ontology_ID>GO:0001975</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process which results in the assembly, arrangement of constituent parts, or disassembly of a membrane. A membrane is a double layer of lipid molecules that encloses all cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins.</Detail>
      <Keyword>Membrane organization</Keyword>
      <Ontology_ID>GO:0061024</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process in which force is generated within muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis.</Detail>
      <Keyword>Muscle contraction</Keyword>
      <Ontology_ID>GO:0006936</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an organelle within a cell. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.</Detail>
      <Keyword>Organelle organization</Keyword>
      <Ontology_ID>GO:0006996</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of cardiac muscle contraction via the regulation of the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol. The sarcoplasmic reticulum is the endoplasmic reticulum of striated muscle, specialised for the sequestration of calcium ions that are released upon receipt of a signal relayed by the T tubules from the neuromuscular junction.</Detail>
      <Keyword>Regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion</Keyword>
      <Ontology_ID>GO:0010881</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of vascular endothelial growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Vascular endothelial growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048010</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses.</Detail>
      <Keyword>Response to corticosterone stimulus</Keyword>
      <Ontology_ID>GO:0051412</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.</Detail>
      <Keyword>Platelet degranulation</Keyword>
      <Ontology_ID>GO:0002576</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.</Detail>
      <Keyword>Platelet activation</Keyword>
      <Ontology_ID>GO:0030168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of excitation of rhodopsin by a photon.</Detail>
      <Keyword>Rhodopsin mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0016056</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>Activation of phospholipase C activity</Keyword>
      <Ontology_ID>GO:0007202</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that initiates the activity of the inactive enzyme adenylate cyclase.</Detail>
      <Keyword>Activation of adenylate cyclase activity</Keyword>
      <Ontology_ID>GO:0007190</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity.</Detail>
      <Keyword>Positive regulation of protein serine/threonine kinase activity</Keyword>
      <Ontology_ID>GO:0071902</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The set of specific processes that generate the ability of an organism to cause disease in another.</Detail>
      <Keyword>Pathogenesis</Keyword>
      <Ontology_ID>GO:0009405</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.</Detail>
      <Keyword>Carbohydrate metabolic process</Keyword>
      <Ontology_ID>GO:0005975</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.</Detail>
      <Keyword>Nitric oxide metabolic process</Keyword>
      <Ontology_ID>GO:0046209</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.</Detail>
      <Keyword>Negative regulation of peptidyl-threonine phosphorylation</Keyword>
      <Ontology_ID>GO:0010801</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis).</Detail>
      <Keyword>Substantia nigra development</Keyword>
      <Ontology_ID>GO:0021762</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency or rate of heart contraction.</Detail>
      <Keyword>Regulation of heart rate</Keyword>
      <Ontology_ID>GO:0002027</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.</Detail>
      <Keyword>Inositol phosphate metabolic process</Keyword>
      <Ontology_ID>GO:0043647</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving small molecules, any monomeric molecule of small relative molecular mass.</Detail>
      <Keyword>Small molecule metabolic process</Keyword>
      <Ontology_ID>GO:0044281</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.</Detail>
      <Keyword>Positive regulation of protein dephosphorylation</Keyword>
      <Ontology_ID>GO:0035307</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Fibroblast growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0008543</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cyclic nucleotide phosphodiesterase activity, the catalysis of the reaction: nucleotide 3',5'-cyclic phosphate + H2O = nucleotide 5'-phosphate.</Detail>
      <Keyword>Positive regulation of cyclic-nucleotide phosphodiesterase activity</Keyword>
      <Ontology_ID>GO:0051343</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of an epidermal growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Epidermal growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007173</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.</Detail>
      <Keyword>Response to calcium ion</Keyword>
      <Ontology_ID>GO:0051592</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the activity of the enzyme nitric-oxide synthase.</Detail>
      <Keyword>Positive regulation of nitric-oxide synthase activity</Keyword>
      <Ontology_ID>GO:0051000</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of rhodopsin-mediated signaling.</Detail>
      <Keyword>Regulation of rhodopsin mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0022400</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving cyclic nucleotides.</Detail>
      <Keyword>Positive regulation of cyclic nucleotide metabolic process</Keyword>
      <Ontology_ID>GO:0030801</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells.</Detail>
      <Keyword>Regulation of cytokinesis</Keyword>
      <Ontology_ID>GO:0032465</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of cardiac muscle contraction.</Detail>
      <Keyword>Regulation of cardiac muscle contraction</Keyword>
      <Ontology_ID>GO:0055117</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the activity of a ryanodine-sensitive calcium-release channel. The ryanodine-sensitive calcium-release channel catalyzes the transmembrane transfer of a calcium ion by a channel that opens when a ryanodine class ligand has been bound by the channel complex or one of its constituent parts.</Detail>
      <Keyword>Positive regulation of ryanodine-sensitive calcium-release channel activity</Keyword>
      <Ontology_ID>GO:0060316</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequence of reactions within a cell required to convert absorbed photons from visible light into a molecular signal. A visible light stimulus is electromagnetic radiation that can be perceived visually by an organism; for organisms lacking a visual system, this can be defined as light with a wavelength within the range 380 to 780 nm.</Detail>
      <Keyword>Phototransduction, visible light</Keyword>
      <Ontology_ID>GO:0007603</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.</Detail>
      <Keyword>Synaptic transmission</Keyword>
      <Ontology_ID>GO:0007268</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components.</Detail>
      <Keyword>Mitochondrion organization</Keyword>
      <Ontology_ID>GO:0007005</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>139</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>100</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>45</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>22</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>111</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>102</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>116</Position>
      <PTM_Type>N6,N6,N6-trimethyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>95</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Vesicle</CellLocal>
      <Ontology_ID>GO:0031982</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Sarcomere</CellLocal>
      <Ontology_ID>GO:0030017</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoskeleton</CellLocal>
      <Ontology_ID>GO:0005856</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Spindle microtubule</CellLocal>
      <Ontology_ID>GO:0005876</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Spindle pole</CellLocal>
      <Ontology_ID>GO:0000922</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleoplasm</CellLocal>
      <Ontology_ID>GO:0005654</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Centrosome</CellLocal>
      <Ontology_ID>GO:0005813</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Growth cone</CellLocal>
      <Ontology_ID>GO:0030426</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular vesicular exosome</CellLocal>
      <Ontology_ID>GO:0070062</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CALM1</Gene_Name>
    <Gene_Alias>CALM; CAM; CAM1; CALM2; CAM2; CAMB; CALM3; CALML2; CAM3; CAMC; CAMIII</Gene_Alias>
    <Gene_ID>801</Gene_ID>
    <Genbank_ACCN>NM_001743</Genbank_ACCN>
    <Protein_ACCN>NP_001734</Protein_ACCN>
    <HGNC_ID>1449</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/808</Gene_URL>
    <UCSC_ID>uc001xyl.2</UCSC_ID>
    <EMBL_ID>ENSG00000160014</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>O95259</Uniprot_ID>
      <Gene_Name>KCNH1</Gene_Name>
      <EBI_ID>EBI-2909270</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-2909270</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O95259-2</Uniprot_ID>
      <Gene_Name>KCNH1</Gene_Name>
      <EBI_ID>EBI-9836801</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-9836801</PPI_EBI_URL>
      <Experiment_Number>8</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q96PM5</Uniprot_ID>
      <Gene_Name>RCHY1</Gene_Name>
      <EBI_ID>EBI-947779</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-947779</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P40136</Uniprot_ID>
      <Gene_Name>cya</Gene_Name>
      <EBI_ID>EBI-457011</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-457011</PPI_EBI_URL>
      <Experiment_Number>8</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P62158</Uniprot_ID>
      <Gene_Name>CALM1</Gene_Name>
      <EBI_ID>EBI-9084208</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-9084208</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13936</Uniprot_ID>
      <Gene_Name>CACNA1C</Gene_Name>
      <EBI_ID>EBI-1038838</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-1038838</PPI_EBI_URL>
      <Experiment_Number>12</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O43303</Uniprot_ID>
      <Gene_Name>CCP110</Gene_Name>
      <EBI_ID>EBI-1566217</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-1566217</PPI_EBI_URL>
      <Experiment_Number>9</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P29274</Uniprot_ID>
      <Gene_Name>ADORA2A</Gene_Name>
      <EBI_ID>EBI-2902702</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-2902702</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P49407</Uniprot_ID>
      <Gene_Name>ARRB1</Gene_Name>
      <EBI_ID>EBI-743313</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-743313</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P00533</Uniprot_ID>
      <Gene_Name>EGFR</Gene_Name>
      <EBI_ID>EBI-297353</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-297353</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q14524</Uniprot_ID>
      <Gene_Name>SCN5A</Gene_Name>
      <EBI_ID>EBI-726858</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-726858</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P25445</Uniprot_ID>
      <Gene_Name>FAS</Gene_Name>
      <EBI_ID>EBI-494743</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-494743</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P26645</Uniprot_ID>
      <Gene_Name>Marcks</Gene_Name>
      <EBI_ID>EBI-911805</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-911805</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P53355</Uniprot_ID>
      <Gene_Name>DAPK1</Gene_Name>
      <EBI_ID>EBI-358616</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-358616</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9HD67</Uniprot_ID>
      <Gene_Name>MYO10</Gene_Name>
      <EBI_ID>EBI-307061</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-307061</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P63104</Uniprot_ID>
      <Gene_Name>YWHAZ</Gene_Name>
      <EBI_ID>EBI-347088</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-347088</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q8WZ42</Uniprot_ID>
      <Gene_Name>TTN</Gene_Name>
      <EBI_ID>EBI-681210</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-681210</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P32121</Uniprot_ID>
      <Gene_Name>ARRB2</Gene_Name>
      <EBI_ID>EBI-714559</EBI_ID>
      <PPI_EBI_URL>EBI-397435,EBI-714559</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Pseudoachondroplasia</Disease_Name>
      <Disease_Detail>Pseudoachondroplasia</Disease_Detail>
      <Disease_DB>PSD012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pseudoachondroplasia?search=CALM1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Catecholaminergic Polymorphic Ventricular Tachycardia</Disease_Name>
      <Disease_Detail>Catecholaminergic Polymorphic Ventricular Tachycardia</Disease_Detail>
      <Disease_DB>CTC001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/catecholaminergic_polymorphic_ventricular_tachycardia?search=CALM1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adolescent Idiopathic Scoliosis</Disease_Name>
      <Disease_Detail>Adolescent Idiopathic Scoliosis</Disease_Detail>
      <Disease_DB>ADL086</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adolescent_idiopathic_scoliosis?search=CALM1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ventricular Tachycardia, Catecholaminergic Polymorphic, 1</Disease_Name>
      <Disease_Detail>Ventricular Tachycardia</Disease_Detail>
      <Disease_DB>VNT013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ventricular_tachycardia_catecholaminergic_polymorphic_1?search=CALM1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ventricular Tachycardia, Catecholaminergic Polymorphic, 4</Disease_Name>
      <Disease_Detail>Ventricular Tachycardia</Disease_Detail>
      <Disease_DB>VNT029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ventricular_tachycardia_catecholaminergic_polymorphic_4?search=CALM1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Otomycosis</Disease_Name>
      <Disease_Detail>Otomycosis</Disease_Detail>
      <Disease_DB>OTM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/otomycosis?search=CALM1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Calm1-Related Catecholaminergic Polymorphic Ventricular Tachycardia</Disease_Name>
      <Disease_Detail>Calm1-Related Catecholaminergic Polymorphic Ventricular Tachycardia</Disease_Detail>
      <Disease_DB>CLM002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/calm1_related_catecholaminergic_polymorphic_ventricular_tachycardia?search=CALM1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Calmodulin in complex with a mutant peptide from human DRP-1 kinase</PDB_Title>
      <PDB_ID>1ZUZ</PDB_ID>
      <Resolution>1.91</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ZUZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Recognition of human death-associated protein kinases by calmodulin</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Complex of IQCG and Ca2+-bound CaM</PDB_Title>
      <PDB_ID>4M1L</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4M1L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Functional and molecular features of the calmodulin-interacting protein IQCG required for haematopoiesis in zebrafish</PubMed_Title>
      <Author>Chen, L.T., et al.</Author>
      <Journal>Nat Commun(2014)5:3811-3811</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24787902?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of Anthrax Edema Factor-Calmodulin-alpha,beta-methyleneadenosine 5'-triphosphate Complex Reveals an Alternative Mode of ATP Binding to the Catalytic Site</PDB_Title>
      <PDB_ID>1S26</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1S26</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of anthrax edema factor-calmodulin-adenosine-5'-(alpha,beta-methylene)-triphosphate complex reveals an alternative mode of ATP binding to the catalytic site</PubMed_Title>
      <Author>Shen, Y., et al.</Author>
      <Journal>Biochem.Biophys.Res.Commun.(2004)317:309-314</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15063758?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Ca2+/CaM:Kv7.4 (KCNQ4) B helix complex</PDB_Title>
      <PDB_ID>4GOW</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GOW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of a Ca(2+)/CaM:Kv7.4 (KCNQ4) B-helix complex provides insight into M current modulation.</PubMed_Title>
      <Author>Xu, Q., et al.</Author>
      <Journal>J.Mol.Biol.(2013)425:378-394</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23178170?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX</PDB_Title>
      <PDB_ID>2X0G</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2X0G</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Basis of the Death-Associated Protein Kinase-Calcium/Calmodulin Regulator Complex.</PubMed_Title>
      <Author>De Diego, I., et al.</Author>
      <Journal>Sci.Signal(2010)3:RA6</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20103772?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3'5' cyclic AMP (cAMP)</PDB_Title>
      <PDB_ID>1XFW</PDB_ID>
      <Resolution>3.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XFW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor.</PubMed_Title>
      <Author>Shen, Y., et al.</Author>
      <Journal>EMBO J.(2005)24:929-941</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15719022?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION STRUCTURE OF THE COMPLEX BETWEEN CALMODULIN AND A PEPTIDE FROM CALCINEURIN A</PDB_Title>
      <PDB_ID>2W73</PDB_ID>
      <Resolution>1.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W73</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Domain Swapping and Different Oligomeric States for the Complex between Calmodulin and the Calmodulin-Binding Domain of Calcineurin A</PubMed_Title>
      <Author>Majava, V., et al.</Author>
      <Journal>Plos One(2009)4:E5402</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19404396?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF SU6656-BOUND CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II DELTA IN COMPLEX WITH CALMODULIN</PDB_Title>
      <PDB_ID>2WEL</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WEL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the Camkiidelta/Calmodulin Complex Reveals the Molecular Mechanism of Camkii Kinase Activation.</PubMed_Title>
      <Author>Rellos, P., et al.</Author>
      <Journal>Plos Biol.(2010)8:426</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20668654?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Kv7.1 proximal C-terminal Domain in Complex with Calmodulin</PDB_Title>
      <PDB_ID>4V0C</PDB_ID>
      <Resolution>2.86</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4V0C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis of a Kv7.1 Potassium Channel Gating Module: Studies of the Intracellular C-Terminal Domain in Complex with Calmodulin.</PubMed_Title>
      <Author>Sachyani, D., et al.</Author>
      <Journal>Structure(2014)22:1582</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/25441029?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Calmodulin/IQ-AA domain complex</PDB_Title>
      <PDB_ID>2F3Z</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2F3Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of Calmodulin Bound to the Hydrophobic IQ Domain of the Cardiac Ca(v)1.2 Calcium Channel.</PubMed_Title>
      <Author>Fallon, J.L., et al.</Author>
      <Journal>Structure(2005)13:1881-1886</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16338416?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Voltage-gated sodium channel 1.2 C-terminal domain in complex with FGF13U and Ca2+/calmodulin</PDB_Title>
      <PDB_ID>4JPZ</PDB_ID>
      <Resolution>3.02</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JPZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural analyses of Ca(2+)/CaM interaction with NaV channel C-termini reveal mechanisms of calcium-dependent regulation.</PubMed_Title>
      <Author>Wang, C., et al.</Author>
      <Journal>Nat Commun(2014)5:4896-4896</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/25232683?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Calmodulin with small bend in central helix</PDB_Title>
      <PDB_ID>4BW8</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4BW8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic Snapshots of Initial Steps in the Collapse of the Calmodulin Central Helix</PubMed_Title>
      <Author>Kursula, P., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2014)70:24</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24419375?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Ca2+/CaM-CaV1.2 pre-IQ/IQ domain complex</PDB_Title>
      <PDB_ID>3OXQ</PDB_ID>
      <Resolution>2.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OXQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Multiple C-terminal tail Ca(2+)/CaMs regulate Ca(V)1.2 function but do not mediate channel dimerization.</PubMed_Title>
      <Author>Kim, E.Y., et al.</Author>
      <Journal>Embo J.(2010)29:3924-3938</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20953164?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The complex Structure of Calmodulin Bound to a Calcineurin Peptide</PDB_Title>
      <PDB_ID>2R28</PDB_ID>
      <Resolution>1.86</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2R28</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The complex structure of calmodulin bound to a calcineurin peptide.</PubMed_Title>
      <Author>Ye, Q., et al.</Author>
      <Journal>Proteins(2008)73:19-27</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18384083?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Ca2+/CaM-CaV2.2 IQ domain (without cloning artifact, HM to TV) complex</PDB_Title>
      <PDB_ID>3DVJ</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DVJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of Ca(V)2 Ca(2+)/CaM-IQ Domain Complexes Reveal Binding Modes that Underlie Calcium-Dependent Inactivation and Facilitation.</PubMed_Title>
      <Author>Kim, E.Y., et al.</Author>
      <Journal>Structure(2008)16:1455-1467</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18940602?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CALMODULIN STRUCTURE REFINED AT 1.7 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1CLL</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CLL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calmodulin structure refined at 1.7 A resolution.</PubMed_Title>
      <Author>Chattopadhyaya, R., et al.</Author>
      <Journal>J.Mol.Biol.(1992)228:1177-1192</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1474585?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure analysis of the adenylyl cyclaes catalytic domain of adenylyl cyclase toxin of Bordetella pertussis in presence of c-terminal calmodulin</PDB_Title>
      <PDB_ID>1YRT</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YRT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin.</PubMed_Title>
      <Author>Guo, Q., et al.</Author>
      <Journal>Embo J.(2005)24:3190-3201</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16138079?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DRUG BINDING BY CALMODULIN: CRYSTAL STRUCTURE OF A CALMODULIN-TRIFLUOPERAZINE COMPLEX</PDB_Title>
      <PDB_ID>1CTR</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CTR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex.</PubMed_Title>
      <Author>Cook, W.J., et al.</Author>
      <Journal>Biochemistry(1994)33:15259-15265</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7803388?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Pseudo-atomic model of the Aquaporin-0/Calmodulin complex derived from electron microscopy</PDB_Title>
      <PDB_ID>3J41</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_Method>ELECTRON MICROSCOPY</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3J41</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Allosteric mechanism of water-channel gating by Ca(2+)-calmodulin.</PubMed_Title>
      <Author>Reichow, S.L., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2013)20:1085-1092</Journal>
      <PubMed_ID>23893133</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The structure of Ca2+ Sensor (Case-12)</PDB_Title>
      <PDB_ID>3O78</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3O78</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structure of Ca2+ sensor Case16 reveals the mechanism of reaction to low Ca2+ concentrations</PubMed_Title>
      <Author>Leder, L., et al.</Author>
      <Journal>Sensors (Basel)(2010)10:8143-8160</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22163646?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN CALMODULIN IN COMPLEX WITH A DAP KINASE-1 MUTANT (W305Y) PEPTIDE</PDB_Title>
      <PDB_ID>2Y4V</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2Y4V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Journey Through the Dap Kinase Architecture</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Human iNOS Reductase and Calmodulin Complex</PDB_Title>
      <PDB_ID>3HR4</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HR4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Regulation of Interdomain Interactions by CaM in Inducible Nitric Oxide Synthase</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Calmodulin complexed with a peptide from a human death-associated protein kinase</PDB_Title>
      <PDB_ID>1WRZ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WRZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The mode of binding of calmodulin to death-associated protein kinases</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Complex of IQCG and Ca2+-free CaM</PDB_Title>
      <PDB_ID>4LZX</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4LZX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Functional and molecular features of the calmodulin-interacting protein IQCG required for haematopoiesis in zebrafish</PubMed_Title>
      <Author>Chen, L.T., et al.</Author>
      <Journal>Nat Commun(2014)5:3811-3811</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24787902?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Calmodulin in complex with strontium</PDB_Title>
      <PDB_ID>4BW7</PDB_ID>
      <Resolution>1.81</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4BW7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic Snapshots of Initial Steps in the Collapse of the Calmodulin Central Helix</PubMed_Title>
      <Author>Kursula, P., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2014)70:24</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24419375?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin</PDB_Title>
      <PDB_ID>1K93</PDB_ID>
      <Resolution>2.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1K93</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin.</PubMed_Title>
      <Author>Drum, C.L., et al.</Author>
      <Journal>Nature(2002)415:396-402</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11807546?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Calmodulin/nematode CA2+/Calmodulin dependent kinase kinase fragment</PDB_Title>
      <PDB_ID>1IQ5</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IQ5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Target-induced conformational adaptation of calmodulin revealed by the crystal structure of a complex with nematode Ca(2+)/calmodulin-dependent kinase kinase peptide</PubMed_Title>
      <Author>Kurokawa, H., et al.</Author>
      <Journal>J.Mol.Biol.(2001)312:59-68</Journal>
      <PubMed_ID>11545585</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Kv7.1 proximal C-terminal Domain in Complex with Calmodulin</PDB_Title>
      <PDB_ID>4UMO</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4UMO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Basis of a Kv7.1 Potassium Channel Gating Module: Studies of the Intracellular C-Terminal Domain in Complex with Calmodulin</PubMed_Title>
      <Author>Sachyani, D., et al.</Author>
      <Journal>Structure(2014)22:1582</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/25441029?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of MARCKS calmodulin binding domain peptide complexed with Ca2+/Calmodulin</PDB_Title>
      <PDB_ID>1IWQ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IWQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a MARCKS peptide containing the calmodulin-binding domain in complex with Ca(2+)-calmodulin</PubMed_Title>
      <Author>Yamauchi, E., et al.</Author>
      <Journal>NAT.STRUCT.BIOL.(2003)10:226-231</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12577052?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Voltage-gated sodium channel 1.5 C-terminal domain in complex with FGF12B and Ca2+/calmodulin</PDB_Title>
      <PDB_ID>4JQ0</PDB_ID>
      <Resolution>3.84</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JQ0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural analyses of Ca(2+)/CaM interaction with NaV channel C-termini reveal mechanisms of calcium-dependent regulation.</PubMed_Title>
      <Author>Wang, C., et al.</Author>
      <Journal>Nat Commun(2014)5:4896-4896</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/25232683?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>RECOMBINANT VERTEBRATE CALMODULIN COMPLEXED WITH BA</PDB_Title>
      <PDB_ID>2V02</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2V02</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Structural Insight Into Lead Neurotoxicity and Calmodulin Activation by Heavy Metals.</PubMed_Title>
      <Author>Kursula, P., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.F(2007)63:653</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17671360?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>TARGET ENZYME RECOGNITION BY CALMODULIN: 2.4 ANGSTROMS STRUCTURE OF A CALMODULIN-PEPTIDE COMPLEX</PDB_Title>
      <PDB_ID>1CDL</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CDL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex.</PubMed_Title>
      <Author>Meador, W.E., et al.</Author>
      <Journal>Science(1992)257:1251-1255</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1519061?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of Mg2+ bound N-terminal domain of calmodulin in the presence of Zn2+</PDB_Title>
      <PDB_ID>3UCY</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3UCY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray Structures of Magnesium and Manganese Complexes with the N-Terminal Domain of Calmodulin: Insights into the Mechanism and Specificity of Metal Ion Binding to an EF-Hand.</PubMed_Title>
      <Author>Senguen, F.T., et al.</Author>
      <Journal>Biochemistry(2012)51:6182-6194</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22803592?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CALMODULIN COMPLEXED WITH CAV1.1 IQ PEPTIDE</PDB_Title>
      <PDB_ID>2VAY</PDB_ID>
      <Resolution>1.94</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2VAY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Determinants in Cav1 Channels that Regulate the Ca2+ Sensitivity of Bound Calmodulin.</PubMed_Title>
      <Author>Halling, D.B., et al.</Author>
      <Journal>J.Biol.Chem.(2009)284:20041-20051</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19473981?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Voltage-gated Sodium Channel 1.5 (Nav1.5) C-terminal domain in complex with Calmodulin poised for activation</PDB_Title>
      <PDB_ID>4OVN</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4OVN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Regulation of the NaV1.5 cytoplasmic domain by calmodulin.</PubMed_Title>
      <Author>Gabelli, S.B., et al.</Author>
      <Journal>Nat Commun(2014)5:5126</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/25370050?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 10 millimolar exogenously added calcium chloride</PDB_Title>
      <PDB_ID>1XFX</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XFX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor.</PubMed_Title>
      <Author>Shen, Y., et al.</Author>
      <Journal>EMBO J.(2005)24:929-941</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15719022?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>1.35 A crystal structure of the NaV1.5 DIII-IV-Ca/CaM complex</PDB_Title>
      <PDB_ID>4DJC</PDB_ID>
      <Resolution>1.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DJC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic basis for calcium regulation of sodium channels.</PubMed_Title>
      <Author>Sarhan, M.F., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2012)109:3558-3563</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22331908?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP</PDB_Title>
      <PDB_ID>1XFV</PDB_ID>
      <Resolution>3.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XFV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor.</PubMed_Title>
      <Author>Shen, Q., et al.</Author>
      <Journal>EMBO J.(2005)24:929-941</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15719022?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CALMODULIN/RAT CA2+/CALMODULIN DEPENDENT PROTEIN KINASE FRAGMENT</PDB_Title>
      <PDB_ID>1CKK</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_Method>NMR</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CKK</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>A novel target recognition revealed by calmodulin in complex with Ca2+-calmodulin-dependent kinase kinase.</PubMed_Title>
      <Author>Osawa, M., et al.</Author>
      <Journal>Nat.Struct.Biol.(1999)6:819-824</Journal>
      <PubMed_ID>10467092</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Calmodulin/IQ domain complex</PDB_Title>
      <PDB_ID>2F3Y</PDB_ID>
      <Resolution>1.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2F3Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of Calmodulin Bound to the Hydrophobic IQ Domain of the Cardiac Ca(v)1.2 Calcium Channel.</PubMed_Title>
      <Author>Fallon, J.L., et al.</Author>
      <Journal>Structure(2005)13:1881-1886</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16338416?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of MG2+ bound N-Terminal domain of Calmodulin</PDB_Title>
      <PDB_ID>3UCW</PDB_ID>
      <Resolution>1.76</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3UCW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray Structures of Magnesium and Manganese Complexes with the N-Terminal Domain of Calmodulin: Insights into the Mechanism and Specificity of Metal Ion Binding to an EF-Hand.</PubMed_Title>
      <Author>Senguen, F.T., et al.</Author>
      <Journal>Biochemistry(2012)51:6182-6194</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22803592?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of ca2+-calmodulin in complex with a trpv1 c-terminal peptide</PDB_Title>
      <PDB_ID>3SUI</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3SUI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Distinct properties of Ca2+-calmodulin binding to N- and C-terminal regulatory regions of the TRPV1 channel.</PubMed_Title>
      <Author>Lau, S.Y., et al.</Author>
      <Journal>J.Gen.Physiol.(2012)140:541-555</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23109716?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 2' deoxy, 3' anthraniloyl ATP</PDB_Title>
      <PDB_ID>1LVC</PDB_ID>
      <Resolution>3.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LVC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins</PubMed_Title>
      <Author>Shen, Y., et al.</Author>
      <Journal>Embo J.(2002)21:6721-6732</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12485993?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of calmodulin complexed with a peptide</PDB_Title>
      <PDB_ID>3EWT</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EWT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural insights into the mechanism of calmodulin binding to death receptors</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of calmodulin complexed with a peptide</PDB_Title>
      <PDB_ID>3EWV</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EWV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural insights into the mechanism of calmodulin binding to death receptors</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of Ca2+/Calmodulin complexed with myristoylated CAP-23/NAP-22 peptide</PDB_Title>
      <PDB_ID>1L7Z</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L7Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a myristoylated CAP-23/NAP-22 N-terminal domain complexed with Ca2+/calmodulin</PubMed_Title>
      <Author>Matsubara, M., et al.</Author>
      <Journal>EMBO J.(2004)23:712-718</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14765114?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the calmodulin-bound Cav1.2 C-terminal regulatory domain dimer</PDB_Title>
      <PDB_ID>3G43</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3G43</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of dimeric cardiac L-type calcium channel regulatory domains bridged by Ca2+{middle dot}calmodulins.</PubMed_Title>
      <Author>Fallon, J.L., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2009)106:5135-5140</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19279214?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure analysis of the adenylyl cyclaes catalytic domain of adenylyl cyclase toxin of Bordetella pertussis in presence of c-terminal calmodulin and 1mM calcium chloride</PDB_Title>
      <PDB_ID>1YRU</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YRU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin</PubMed_Title>
      <Author>Guo, Q., et al.</Author>
      <Journal>Embo J.(2005)24:3190-3201</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16138079?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin and 3' deoxy-ATP</PDB_Title>
      <PDB_ID>1K90</PDB_ID>
      <Resolution>2.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1K90</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>1 - 1K90 :</PubMed_Title>
      <Author>Drum, C.L., et al.</Author>
      <Journal>Nature(2002)415:396-402</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11807546?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution Structure of Ca2+/Calmodulin bound to the C-terminal Domain of Petunia Glutamate Decarboxylase</PDB_Title>
      <PDB_ID>1NWD</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_Method>ELECTRON MICROSCOPY</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NWD</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Structural Basis for Simultaneous Binding of Two Carboxy-terminal Peptides of Plant Glutamate Decarboxylase to Calmodulin</PubMed_Title>
      <Author>Yap, K.L., et al.</Author>
      <Journal>J.Mol.Biol.(2003)328:193-204</Journal>
      <PubMed_ID>12684008</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human Myosin 1c in complex with calmodulin in the pre-power stroke state</PDB_Title>
      <PDB_ID>4BYF</PDB_ID>
      <Resolution>2.74</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4BYF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of Human Myosin 1C-the Motor in Glut4 Exocytosis: Implications for Ca(2+) Regulation and 14-3-3 Binding.</PubMed_Title>
      <Author>Munnich, S., et al.</Author>
      <Journal>J.Mol.Biol.(2014)426:2070</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24636949?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the C-terminus of voltage-gated sodium channel in complex with FGF13 and CaM</PDB_Title>
      <PDB_ID>4DCK</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DCK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Ternary Complex of a NaV C-Terminal Domain, a Fibroblast Growth Factor Homologous Factor, and Calmodulin.</PubMed_Title>
      <Author>Wang, C., et al.</Author>
      <Journal>Structure(2012)20:1167-1176</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22705208?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Ca2+/CaM-CaV2.2 IQ domain complex</PDB_Title>
      <PDB_ID>3DVE</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DVE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of Ca(V)2 Ca(2+)/CaM-IQ Domain Complexes Reveal Binding Modes that Underlie Calcium-Dependent Inactivation and Facilitation.</PubMed_Title>
      <Author>Kim, E.Y., et al.</Author>
      <Journal>Structure(2008)16:1455-1467</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18940602?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of nucleotide-free Myosin 1b residues 1-728 with bound Calmodulin</PDB_Title>
      <PDB_ID>4L79</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4L79</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A vertebrate myosin-I structure reveals unique insights into myosin mechanochemical tuning.</PubMed_Title>
      <Author>Shuman, H., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2014)111:2116-2121</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24469830?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the EF3-CaM complexed with PMEApp</PDB_Title>
      <PDB_ID>1PK0</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PK0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.</PubMed_Title>
      <Author>Shen, Y., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2004)101:3242-3247</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14978283?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of anthrax edema factor (EF) in complex with calmodulin</PDB_Title>
      <PDB_ID>1XFY</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XFY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor.</PubMed_Title>
      <Author>Shen, Y., et al.</Author>
      <Journal>EMBO J.(2005)24:929-941</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15719022?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The structure of Ca2+ Sensor (Case-16)</PDB_Title>
      <PDB_ID>3O77</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3O77</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structure of Ca2+ sensor Case16 reveals the mechanism of reaction to low Ca2+ concentrations</PubMed_Title>
      <Author>Leder, L., et al.</Author>
      <Journal>Sensors (Basel)(2010)10:8143-8160</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22163646?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the plectin 1a actin-binding domain/N-terminal domain of calmodulin complex</PDB_Title>
      <PDB_ID>4Q57</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4Q57</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the plectin 1a actin-binding domain/N-terminal domain of calmodulin complex</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>2.0 A crystal structure of the CaV1.2 IQ domain-Ca/CaM complex</PDB_Title>
      <PDB_ID>2BE6</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2BE6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights into voltage-gated calcium channel regulation from the structure of the Ca(V)1.2 IQ domain-Ca(2+)/calmodulin complex</PubMed_Title>
      <Author>van Petegem, F., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2005)12:1108-1115</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16299511?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>crystal structure analysis of the CyaA/C-Cam with PMEAPP</PDB_Title>
      <PDB_ID>1ZOT</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ZOT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin.</PubMed_Title>
      <Author>Guo, Q., et al.</Author>
      <Journal>Embo J.(2005)24:3190-3201</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16138079?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of calmodulin bound to its recognition site from calcineurin</PDB_Title>
      <PDB_ID>4Q5U</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4Q5U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Stoichiometry of the calcineurin regulatory domain-calmodulin complex.</PubMed_Title>
      <Author>Dunlap, T.B., et al.</Author>
      <Journal>Biochemistry(2014)53:5779-5790</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/25144868?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of anthrax edema factor (EF) in complex with calmodulin in the presence of 1 millimolar exogenously added calcium chloride</PDB_Title>
      <PDB_ID>1XFZ</PDB_ID>
      <Resolution>3.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XFZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor.</PubMed_Title>
      <Author>Shen, Y., et al.</Author>
      <Journal>EMBO J.(2005)24:929-941</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15719022?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the adenylyl cyclase domain of anthrax edema factor (EF) in complex with calmodulin, 3',5' cyclic AMP (cAMP), and pyrophosphate</PDB_Title>
      <PDB_ID>1SK6</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SK6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate.</PubMed_Title>
      <Author>Guo, Q., et al.</Author>
      <Journal>J.Biol.Chem.(2004)279:29427-29435</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15131111?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>1.7-A structure of calmodulin bound to a peptide from DAP kinase</PDB_Title>
      <PDB_ID>1YR5</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YR5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Recognition of human death-associated protein kinases by calmodulin</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Structure of Mn2+-bound N-terminal domain of calmodulin in the presence of Zn2+</PDB_Title>
      <PDB_ID>3UCT</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3UCT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray Structures of Magnesium and Manganese Complexes with the N-Terminal Domain of Calmodulin: Insights into the Mechanism and Specificity of Metal Ion Binding to an EF-Hand.</PubMed_Title>
      <Author>Senguen, F.T., et al.</Author>
      <Journal>Biochemistry(2012)51:6182-6194</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22803592?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solvation effect in conformational changes of EF-hand proteins: X-ray structure of Ca2+-saturated double mutant Q41L-K75I of N-domain of calmodulin</PDB_Title>
      <PDB_ID>2I08</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2I08</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solvation effect in conformational changes of EF-hand proteins: X-ray structure of double mutant Q41L-K75I of N-domain of calmodulin</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Structure of a Calmodulin Complex</PDB_Title>
      <PDB_ID>3BYA</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3BYA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of a Calmodulin Complex</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>RECOMBINANT VERTEBRATE CALMODULIN COMPLEXED WITH PB</PDB_Title>
      <PDB_ID>2V01</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2V01</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Structural Insight Into Lead Neurotoxicity and Calmodulin Activation by Heavy Metals.</PubMed_Title>
      <Author>Kursula, P., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.F(2007)63:653</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17671360?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of IP3 3-K calmodulin binding region in complex with Calmodulin</PDB_Title>
      <PDB_ID>4UPU</PDB_ID>
      <Resolution>2.34</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4UPU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A New Calmodulin Binding Motif for Inositol 1,4,5-Trisphosphate 3-Kinase Regulation.</PubMed_Title>
      <Author>Franco-Echevarria, E., et al.</Author>
      <Journal>Biochem.J.(2014)463:319</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/25101901?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of anthrax edema factor (EF) truncation mutant, EF-delta 64 in complex with calmodulin</PDB_Title>
      <PDB_ID>1XFU</PDB_ID>
      <Resolution>3.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XFU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor.</PubMed_Title>
      <Author>Shen, Y., et al.</Author>
      <Journal>EMBO J.(2005)24:929-941</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15719022?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Trapped intermediate of calmodulin</PDB_Title>
      <PDB_ID>1Y6W</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y6W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of a Trapped Intermediate of Calmodulin: Calcium Regulation of EF-hand Proteins from a New Perspective.</PubMed_Title>
      <Author>Grabarek, Z., et al.</Author>
      <Journal>J.Mol.Biol.(2005)346:1351-1366</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15713486?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Ca2+/CaM-CaV2.3 IQ domain complex</PDB_Title>
      <PDB_ID>3DVK</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DVK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of Ca(V)2 Ca(2+)/CaM-IQ Domain Complexes Reveal Binding Modes that Underlie Calcium-Dependent Inactivation and Facilitation.</PubMed_Title>
      <Author>Kim, E.Y., et al.</Author>
      <Journal>Structure(2008)16:1455-1467</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18940602?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Ca2+/CaM-CaV2.1 IQ domain complex</PDB_Title>
      <PDB_ID>3DVM</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DVM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of Ca(V)2 Ca(2+)/CaM-IQ Domain Complexes Reveal Binding Modes that Underlie Calcium-Dependent Inactivation and Facilitation.</PubMed_Title>
      <Author>Kim, E.Y., et al.</Author>
      <Journal>Structure(2008)16:1455-1467</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18940602?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05031</Pathway_ID>
      <Pathway_Title>Amphetamine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04922</Pathway_ID>
      <Pathway_Title>Glucagon signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04750</Pathway_ID>
      <Pathway_Title>Inflammatory mediator regulation of TRP channels</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04713</Pathway_ID>
      <Pathway_Title>Circadian entrainment</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04728</Pathway_ID>
      <Pathway_Title>Dopaminergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04970</Pathway_ID>
      <Pathway_Title>Salivary secretion</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Digestive system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04740</Pathway_ID>
      <Pathway_Title>Olfactory transduction</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04745</Pathway_ID>
      <Pathway_Title>Phototransduction - fly</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04916</Pathway_ID>
      <Pathway_Title>Melanogenesis</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04745</Pathway_ID>
      <Pathway_Title>Phototransduction - fly</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04744</Pathway_ID>
      <Pathway_Title>Phototransduction</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04114</Pathway_ID>
      <Pathway_Title>Oocyte meiosis</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04020</Pathway_ID>
      <Pathway_Title>Calcium signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04015</Pathway_ID>
      <Pathway_Title>Rap1 signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04722</Pathway_ID>
      <Pathway_Title>Neurotrophin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04261</Pathway_ID>
      <Pathway_Title>Adrenergic signaling in cardiomyocytes</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Circulatory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04626</Pathway_ID>
      <Pathway_Title>Plant-pathogen interaction</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05133</Pathway_ID>
      <Pathway_Title>Pertussis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05031</Pathway_ID>
      <Pathway_Title>Amphetamine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05010</Pathway_ID>
      <Pathway_Title>Alzheimer's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04744</Pathway_ID>
      <Pathway_Title>Phototransduction</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05152</Pathway_ID>
      <Pathway_Title>Tuberculosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04022</Pathway_ID>
      <Pathway_Title>cGMP-PKG signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04713</Pathway_ID>
      <Pathway_Title>Circadian entrainment</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04270</Pathway_ID>
      <Pathway_Title>Vascular smooth muscle contraction</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Circulatory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04971</Pathway_ID>
      <Pathway_Title>Gastric acid secretion</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Digestive system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04921</Pathway_ID>
      <Pathway_Title>Oxytocin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04014</Pathway_ID>
      <Pathway_Title>Ras signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04720</Pathway_ID>
      <Pathway_Title>Long-term potentiation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04024</Pathway_ID>
      <Pathway_Title>cAMP signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04070</Pathway_ID>
      <Pathway_Title>Phosphatidylinositol signaling system</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04912</Pathway_ID>
      <Pathway_Title>GnRH signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04915</Pathway_ID>
      <Pathway_Title>Estrogen signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00240005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00470001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00470002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00470003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00470004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00470006</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00470007</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD11630001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2015-04-08</Create_Date>
</Organism_Record>